VALIDATED SPECTROPHOTOMETRIC METHODS BASED ON CHARGE TRANSFER COMPLEXATION REACTION FOR THE DETERMINATION OF VALACYCLOVIR HYDROCHLORIDE AS ANTIVIRAL DRUG IN PHARMACEUTICAL FORMULATIONS

Authors

  • ALI H. AMIN Deanship of Scientific Research, Umm Al-Qura University, Makkah, Saudi Arabia, Zoology Department, Faculty of Science, Mansoura University, Mansoura, Egypt https://orcid.org/0000-0002-9752-602X
  • RAGAA EL SHEIKH Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
  • AHMED O. YOUSSEF Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt https://orcid.org/0000-0003-0859-5304
  • GHADA M. ABDEL FATTAH Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
  • AYMAN A. GOUDA Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt

DOI:

https://doi.org/10.22159/ijap.2022v14i3.43906

Keywords:

Valacyclovir HCl, Spectrophotometry, Quinalizarin, Alizarin red S, Charge transfer reaction, Pharmaceutical formulations

Abstract

Objective: The present study aims to develop and validate two simple, sensitive, accurate, precise and economical spectrophotometric methods for the determination of valacyclovir HCl (VAL) in pure form and pharmaceutical formulations.

Methods: The developed methods are based on the formation of charge-transfer complex between VAL as n-electron donor and quinalizarin (Quinz) or alizarin red S (ARS) as π-acceptor in methanol to form highly colored chromogens, which showed an absorption maximum at 565 and 540 nm using Quinz and ARS, respectively. The optimization of the reaction conditions such as the type of solvent, reagent concentration and reaction time were investigated.

Results: Under the optimum conditions, Beer’s law is obeyed in the concentration ranges 0.5–16 and 1.0–20 μg/ml using Quinz and ARS, respectively, with good correlation coefficient (r2 ≥ 0.9994) and with a relative standard deviation (RSD% ≤ 0.70). The limits of detection and quantification were found to be 0.15 and 0.30 µg/ml for Quinz and 0.50 and 1.0 µg/ml for ARS.

Conclusion: The methods were successfully applied to the determination of VAL in its pharmaceutical formulations and the validity assesses by applying the standard addition technique. Results obtained by the proposed methods for the pure VAL and commercial tablets agreed well with those obtained by the reported method.

Downloads

Download data is not yet available.

References

United States Pharmacopeia. Valacyclovir hydrochloride, USP 41, NF 36, USP Convention 12601, Tweinbrook Parkway, Rockville, MD 20852. Vol. 1; 2018. p. 4264-5.

Smiley ML, Murray A, de Miranda P. Valacyclovir HCl (Valtrex™): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster. Advances in Experimental Medicine and Biology. 1996;4:33-9. doi: 10.1007/978-1-4757-9209-6_4.

Landowski CP, Sun D, Foster DR, Menon SS, Barnett JL, Welage LS, Ramachandran C, Amidon GL. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J Pharmacol Exp Ther. 2003;306(2):778-86. doi: 10.1124/jpet.103.051011, PMID 12750437.

Sp ST, MM, ND, DJ. Screening and optimization of valacyclovir niosomes by design of experiments. Int J App Pharm. 2018;10(1):79-85. doi: 10.22159/ijap.2018v10i1.22566.

Sathis Kumar D, Prashanthi BDN, Harani A, Anusha P. Method development and validation of valacyclovir hydrochloride and ritonavir in tablet dosage form using reverse phase high performance liquid chromatography. Jurnal Teknologi. 2015;76(1):39-45. doi: 10.11113/jt.v76.3093.

Deshpande MM, Kasture VS, Mohan M, Chaudhari S. Development and validation of bioanalytical method for the determination of valcyclovir HCl in human plasma by liquid chromatoghraphy. Eur J Anal Chem. 2015;10:106-12.

Patil Pallavi M, Wankhede Sagar B, Chaudhari Praveen D. Stability-indicating hptlc method for estimation of valacyclovir hydrochloride in bulk and pharmaceutical dosage form in presence of its alkaline hydrolysis degradation product. Int J Pharm Biol Sci. 2014:5;P203:186.

Bhavar GB, Pekamwar SS, Aher KB, Chaudhari SR. Development and validation of RP-HPLC method for the determination of valacyclovir hydrochloride and its related substances in tablet formulation. Int J Pharm Sci Rev Res. 2014;25:53-8.

Rasool SK, Naik DV, Prasad Babu D, Nalluri BN. RP-HPLC method for the estimation of valacyclovir in bulk and pharmaceutical formulations. Int J Pharm Pharm Sci. 2012;4:214-18.

Sugumaran M, Bharathi V, Hemachander R, Lakshmi M. RP-HPLC method for the determination of valacyclovir in bulk and pharmaceutical formulation. Pharm Chem. 2011;3:190-4.

Devarushi US, Shetti NP, Bukkitgar SD, Tuwar SM. Electrochemical behavior of an anti-viral drug valacyclovir at carbon paste electrode and its analytical application. Russ J Electrochem. 2018;54(10):760-8. doi: 10.1134/S1023193518100026.

Pınar PT, Senturk Z. Voltammetric investigation of antiviral drug valacyclovir at a boron-doped diamond electrode in different electrolyte media: its determination enhanced by anionic surfactant in pharmaceuticals and biological fluids. Curr Pharm Anal. 2017;13(2):175-87. doi: 10.2174/1573412912666160901102844.

Jain R, Pandey P. Electrocatalytic quantification of antiviral drug valacyclovir. Ionics. 2015;21(12):3279-87. doi: 10.1007/s11581-015-1511-2.

Tarinc D, Golcu A. Electrochemical behavior of valacyclovir and its square wave and differential pulse voltammetric determination in pharmaceuticals and biological fluids. Russ J Electrochem. 2015;51(2):149-58. doi: 10.1134/S1023193515020135.

Uslu B, Ozkan SA, Senturk Z. Electrooxidation of the antiviral drug valacyclovir and its square-wave and differential pulse voltammetric determination in pharmaceuticals and human biological fluids. Anal Chim Acta. 2006;555(2):341-7. doi: 10.1016/j.aca.2005.09.034.

Derayea SM, Omar MA, Mostafa IM, Hammad MA. Enhancement of the sensitivity of valacyclovir and acyclovir for their spectrofluorimetric determination in human plasma. RSC Adv. 2015;5(96):78920-6. doi: 10.1039/C5RA11635J.

Derayea SM, Mostafa IM, Omar MA. Spectrofluorimetric and TLC-densitometric methods for a stability indicating assay of valacyclovir hydrochloride in the presence of its degradation product. RSC Adv. 2014;4(80):42308-15. doi: 10.1039/C4RA06677D.

Caglar S. Determination of valacyclovir hydrochloride in tablets and spiked plasma samples by spectrofluorimetry. J Anal Chem. 2014;69(4):362-6. doi: 10.1134/S1061934814040145.

Lade PD, Patil SV, Kadam SS, Tipugade OB, Nakhare PG. Analytical method development and validation of valacyclovir to estimate from its formulation. Curr Pharm Res. 2019;9:3086-94.

Alhemiary NAF, Al-Hakemi AN. Asimple assay methods development and validation of vancyclovir in blood, urine and pharmaceutical dosage forms by spectrophotometry, Indo. Am J Pharmacol Sci. 2016;3:586-93.

Narendra R, Pavan S, Sravani D, Sumanta M, Ganapathi S. Development and validation of new analytical methods for the estimation of valacyclovir hydrochloride in pharmaceutical dosage form. Pharm Lett. 2016;8:296-303.

Gulimi J. Visible spectrophotometric determination of valacyclovir by using aradimethylaminocinnamaldehyde reagent. Int J PharmTech Res. 2014;6:1036-9.

Siva Ramakrishna V, Ravi Kumar D, Malleswara Rao NVN, Ram Babu C. Method development and determination of valacyclovir HCl in pharmaceutical dosage forms by visible spectrophotometry. Int J PharmTech Res. 2012;4:1009-14.

Siva Ramakrishna V, Sudha Lakshmi PB, Ravi Kumar D, Ram Babu C. Spectrophotometric determination of valacyclovir HCl through oxidative coupling reaction in bulk and its pharmaceutical preparations. Int J PharmTech Res. 2012;4:138-42.

Gowtam Potnuru VMK, Krishna Reddy Y, Arjun CH, Prasanthi P, Ramya Krishna M, Chandra Sekhar E. Spectrophotometric method development and validation of valacyclovir hydrochloride in bulk and pharmaceutical dosage form. Res Rev J Pharm Anal. 2012;1:13-8.

Sudhakar Reddy J, Maqsood Ahmed MS, Chakravarth IE, Prabhavathi K. Spectrophotometric estimation of valacyclovir in pharmaceutical preparations. J Chem Pharm Res. 2011;3:773-6.

Ganesh M, Narasimharao CV, Saravana AK, Kamalakannan K, Vinoba M, Mahajan HS, Sivakumar T. UV spectrophotometric method for the estimation of valacyclovir HCl in tablet dosage form. EJ Chem. 2009;6:814-8.

Reddy DVP, Gurupadayya BM, Manohara YN, Bhaskar VV. Spectrophotometric determination of valacyclovir hydrochloride in bulk and pharmaceutical formulations. Asian J Chem. 2007;19:2797-800.

Babu GS, Babu IS, Kumar NK, Yugandhar NM, Raju C. Spectrophotometric determination of valacyclovir in pharmaceutical formulation. Asian J Chem. 2007;19(4)2797-2800.

Rao PLKM, Venugopal V, Anil Kumar G, Vasanthi B, Shiny D, Jyothi D, Shantha Kumari G. Quantification and method validation for valacyclovir hydrochloride in pharmaceutical dosage forms by absorption spectroscopy. Int J Pharm Chem Sci. 2013;2:1762-4.

Dinakaran SK, Botla DNP, Pothula A, Kasssetti K, Avasarala H, Kakaraparthy R. Spectrophotometric and method development and validation for valacyclovir hydrochloride monohydrate and ritonavir in bulk and tablet dosage form using absorption ratio method. Malays J Pharm Sci. 2013;11:21-9.

Sugumaran M, Jothieswari D. Development and validation of spectroscopic method for estimation of valacyclovir in tablet dosage form. Orient J Chem. 2010;26:163-5.

Gouda AA, Malah ZA. Development and validation of sensitive spectrophotometric method for determination of two antiepileptics in pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc. 2013;105:488-96. doi: 10.1016/j.saa.2012.12.053. PMID 23352920.

El Sheikh R, Gouda AA, El-Azzazy R. Spectrophotometric study on the charge transfer complex between sumatriptan succinate and some π-acceptors and alizarin derivatives, Chem Ind Chem Eng Quar. 2013;19:529-40.

Gouda AA, El Sheikh R, El-Azzazy RM. Utility of charge transfer and Ion-Pair complexation for spectrophotometric determination of eletriptan hydrobromide in pure and dosage forms. J Chem. 2013;2013:1-9. doi: 10.1155/2013/402164.

Gouda AA, Abd El-Hay SS, Hashem H. Utilization of alizarin derivatives for the sensitive spectrophotometric determination of two proton pump inhibitors in pharmaceutical formulations. Main Group Chem. 2016;15(1):17-34. doi: 10.3233/MGC-150180.

El Sheikh R, Amin AS, Gouda AA, Negeda OS. Sensitive and validated spectrophotometric method for the assay of proton pump inhibitor dexlansoprazole in pure form and pharmaceutical formulations using alizarin derivatives. Int J Res Ayurveda Pharm. 2018;9:76-82.

International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline, validation of analytical procedures: text and methodology. Vol. Q2. London: ICH, Complementary Guideline on Methodology; 2005. p. R1.

Renny JS, Tomasevich LL, Tallmadge EH, Collum DB. Method of continuous variations: applications of Job plots to the study of molecular associations in organometallic chemistry. Angew Chem Int Ed. 2013;52(46):11998-2013. doi: 10.1002/anie.201304157.

Miller JN, Miller JC. Statistics and chemometrics for analytical chemistry. 5th ed. Englewood Cliffs: Prentice Hall; 2005.

Published

07-05-2022

How to Cite

AMIN, A. H., EL SHEIKH, R., YOUSSEF, A. O., ABDEL FATTAH, G. M., & GOUDA, A. A. (2022). VALIDATED SPECTROPHOTOMETRIC METHODS BASED ON CHARGE TRANSFER COMPLEXATION REACTION FOR THE DETERMINATION OF VALACYCLOVIR HYDROCHLORIDE AS ANTIVIRAL DRUG IN PHARMACEUTICAL FORMULATIONS. International Journal of Applied Pharmaceutics, 14(3), 117–124. https://doi.org/10.22159/ijap.2022v14i3.43906

Issue

Section

Original Article(s)

Most read articles by the same author(s)